MedTrace Logo

POC for the Treatment of Subjects With Moderate AS Using Valvosoft® Non-Invasive Ultrasound Therapy

NCT06650839 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2026-01-07

No results posted yet for this study

Summary

This study is a proof of concept looking at the safety of treating subjects with moderate aortic stenosis using a Non-Invasive Ultrasound Therapy.

Conditions

  • Moderate Aortic Valve Stenosis

Interventions

DEVICE

NIUT

Treatment of moderate aortic stenosis using non-invasive ultrasound therapy delivered by Valvosoft

Sponsors & Collaborators

  • Micro Cro

    collaborator UNKNOWN

  • TWrite

    collaborator UNKNOWN

  • Cardiawave SA

    lead INDUSTRY

Principal Investigators

  • Milos Velinovic, MD, PhD · University Clinical Centre Serbia

  • Danijela Trifunovic-Zamklar, MD, PhD · University Clinical Centre Serbia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-31
Primary Completion
2026-10-31
Completion
2027-12-31

Countries

  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06650839 on ClinicalTrials.gov